| ALHC Stock | | | USD 17.12 -0.89 -4.94% |
The math transform module provides an execution environment for Price Ceiling Movement transformation and related indicators on Alignment Healthcare. The focus on price transformations that reveal shifts in trend structure helps organize trend, volatility, and risk context for Alignment Healthcare.
Most technical analysis of Alignment Healthcare help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Alignment from various momentum indicators to cycle indicators. When you analyze Alignment charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
Alignment Healthcare, Inc., a tech-enabled Medicare advantage company, operates consumer-centric health care platform. The company was founded in 2013 and is based in Orange, California. Alignment Healthcare operates under Healthcare Plans classification in the United States and is traded on NASDAQ Exchange. It employs 847 people. As a large-cap equity, Alignment Healthcare is reviewed for growth durability, margin stability, and risk discipline. Current metrics include P/B of 19.51, profit margin of -0.02%. Alignment Healthcare has a market cap of 3.5 B, ROE of -0.7%.
Methodology
Unless otherwise specified, financial data for Alignment Healthcare LLC is derived from periodic company reporting (annual and quarterly where available). Asset-level metrics are computed daily by Macroaxis LLC and refreshed regularly based on asset type. Alignment (USA Stocks:ALHC) prices are typically delayed by approximately 20 minutes from primary exchanges for listed equities. Data may be delayed depending on reporting sources and market conventions. Assumptions: We primarily rely on public filings and market reference sources, including disclosures published by U.S. Securities and Exchange Commission (SEC) via EDGAR and the U.S. Food & Drug Administration (FDA). Data is normalized for analytical consistency across reporting formats. All analytics are generated using standardized, rules-based models designed to promote consistency and comparability across instruments. Model assumptions, reference parameters, and selected computational inputs are available in the Model Inputs section. If you have questions about our data sources or methodology, please contact Macroaxis Support.
Analyst Sources
Alignment Healthcare LLC may have analyst coverage included in Macroaxis-derived consensus inputs when available. Updates may occur throughout the day.
This content is curated and reviewed by:
Raphi Shpitalnik - Junior Member of Macroaxis Editorial Board
Tracking Alignment Healthcare inside a portfolio is useful because individual winners can still weaken diversification or distort overall risk targets. A disciplined tracking process turns performance data into better decisions instead of more noise.